Q32 Bio Announces $200M Equity Offering; Shares Slip After Hours
Q32 Bio revealed plans for an underwritten public offering of $200 million in common stock and pre-funded warrants, with an underwriter option of up to $30 million. The company said net proceeds will support working capital needs, including research, clinical development and commercialization related to bempikibart. Shares dipped about 6% in after-…